Accumulating data suggest that lamotrigine, which has been available for adult use in epilepsy for more than a decade in clinical practice, also confers effective, well-tolerated control of a range of childhood epilepsies. Lamotrigine is currently approved for the treatment of epilepsy by regulatory authorities in 93 countries, more than 70 of which have approved its use in pediatric patients on the basis of data from well-controlled clinical trials. The controlled clinical trials data have been supplemented over the years by clinical practice data, primarily from uncontrolled studies, confirming or demonstrating additional efficacy of lamotrigine for a range of seizure types. This article reviews the data from well-controlled clinical trials and studies conducted in clinical practice to present an updated perspective on the efficacy and safety of lamotrigine in pediatric patients. (J Child Neurol 2002;17:2S34—2S42).
Get full access to this article
View all access options for this article.
References
1.
Neville Bgr: Fortnightly review: Epilepsy in childhood. BMJ1997;315:924—930.
2.
Holmes GL, Ben-Ari Y: The neurobiology and consequences of epilepsy in the developing brain. Pediatr Res2001;49:320—325.
3.
Baker GA, Jacoby A., Bick D., et al: Quality of life of people with epilepsy: A European study. Epilepsia1997;38:353—362.
4.
Culy CR, Goa KL: Lamotrigine: A review of its use in childhood epilepsy. PaediatrDrugs2000;2:299—330.
5.
Messenheimer JA, Giorgi L., Risner ME: The tolerability of lamotrigine in children . Drug Saf2000;22:303—312.
6.
Motte J., Trevathan E., Arvidsson Jfv, et al: Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med1997;337:1807—1812.
7.
Duchowny M., Pellock JM, Graf WD, et al: A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology1999 ;53:1724—1731.
8.
Frank LM, Enlow T., Holmes GL, et al: Lamictal monotherapy for typical absence seizures in children . Epilepsia1999;40:973—979.
9.
Timmings PL, Richens A.: Lamotrigine as add-on drug in the man-agement of Lennox-Gastaut syndrome. Eur Neurol1992;32:305—307.
10.
Schlumberger E., Chavez F., Palacio L., et al: Lamotrigine in treatment of 120 children with epilepsy. Epilepsia1994;35:359—367.
11.
Donaldson JA , Glauser TA, Olberding LS: Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome). Epilepsia1997;38:68—73.
12.
Eriksson A-S. , Nergardh A., Hoppu K.: The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: A randomized, double-blind, crossover study. Epilepsia1998;39:495—501.
Risner M., Messenheimer J., Giorgi L., et al: The safety and efficacy of Lamictal and valproic acid combination therapy in pediatric epilepsy patients, abstract. Neurology1998;50:A426.
15.
Sandstedt P.: Primary generalized epilepsies in childhood, in Sillanpaa M, Johannessen S, Blenow G, Dam M (eds): Paediatric Epilepsy. Pedersfield, UK: Wrightson Biomedical Publishing, 1990,99-109.
16.
Barron TF, Junt SL, Hoban TF, et al: Lamotrigine monotherapy in children. Pediatr Neurol2000; 23: 160—163.
17.
Besag Fmc, Wallace SJ, Dulac O., et al: Lamotrigine for the treatment of epilepsy in childhood. J Pediatr1995;127:991—997.
18.
Buchanan N. : The use of lamotrigine in juvenile myoclonic epilepsy. Seizure1996;5:149—151.
19.
Sharpe C., Buchanan N.: Juvenile myoclonic epilepsy: Diagnosis, management and outcome. Med J Aust1995;162:133—134.
20.
Morris G., Schimschock J., Vuong A., et al: Broad-spectrum activity of lamotrigine monotherapy in patients with juvenile myoclonic epilepsy, abstract. Epilepsia2000;41(Suppl 7):92.
21.
Biraben A., Allain H., Scarabin JM, et al: Exacerbation of juvenile myoclonic epilepsy with lamotrigine, letter. Neurology2000;55:1758.
22.
Carranzana EJ, Wheeler SD: Exacerbation of juvenile myoclonic epilepsy with lamotrigine, letter. Neurology2001;56:1424.
23.
Veggiotti P. , Cieuta C., Rey E., et al: Lamotrigine in infantile spasms. Lancet1994;344:1375—1376.
24.
Uldall P., Hansen FJ, Tonnby B.: Lamotrigine in Rett syndrome. Neuropediatrics1993;24:339—340.
25.
Stenbom Y., Tonnby B., Hagberg B.: Lamotrigine in Rett syndrome: Treatment experience from a pilot study. Eur Child Adolesc Psychiatry1998;7:49—52.
26.
Kumandas S. , Caksen H., Ciftci A., et al: Lamotrigine in two cases of Rett syndrome . Brain Dev2001;23:240—242.
27.
Genton P.: When antiepileptic drugs aggravate epilepsy. Brain Dev2000;22:75—80.
28.
Guerrini R. , Dravet C., Genton P., et al: Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia1998 ;39:508—512.
29.
Huber B., May T., Seidel M.: Lamotrigine in multi-handicapped, t h e r a p y - r e s i s t a n t e p i l e p t i c p a t i e n t s . C l i n D r u g I n v e s t1998;16:263—277.
30.
Buchanan N. : The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability. Seizure1995;4:233—236.
31.
Coppola G., Pascotto A.: Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: An open trial. Brain Dev1997;19:398—402.
32.
Uvebrant P. , Bauzien PR: Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics1994;25:284—289.
33.
McKee JR, Sunder TR, Vuong A., et al: Lamotrigine adjunctive therapy improves behavior in persons with refractory epilepsy and mental retardation, abstract. Epilepsia2000;41(Suppl 7):91.
34.
McKee JR, Sunder TR, Vuong A., et al: Lamotrigine adjunctive therapy in patients with refractory epilepsy and mental retardation, abstract. Epilepsia2000;41(Suppl 7):91.
35.
Calabrese JR , Bowden CL, Sachs GS, et al: A double-blind, placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression . J Clin Psychiatry1999;60:79—88.
36.
Smith D., Baker G., Davies G., et al: Outcomes of add-on treatment with lamotrigine in partial epilepsy . Epilepsia1993; 34:312—322.
37.
Marciani MG , Stanzione P., Mattia D., et al: Lamotrigine add-on therapy in focal epilepsy: Electroencephalographic and neuropsychological evaluation. Clin Neuropharmacol1998;21:41—47.
38.
Beran RG, Gibson RJ: Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia1998;39:280—282.
39.
Besag Fmc, Dulac O., Alving J., et al: Long-term safety and efficacy of lamotrigine in paediatric patients with epilepsy. Seizure1997;6:51—56.
40.
Kluger G., Berz K., Holthausen H.: The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy. Eur J Paediatr Neurol2001 ;5:37—40.
41.
Gilman JT, Duchowny MS, Messenheimer JA, et al: Long-term tolerability of lamotrigine in pediatric patients, abstract. Ann Neurol2001;50(Suppl 1):S92.
42.
Messenheimer JA, Mullens EL, Giorgi L., et al: Safety review of adult clinical trial experience with lamotrigine. Drug Saf1998 ;18:281—296.
43.
Guberman AH , Besag Fmc, Brodie MJ, et al: Lamotrigine-associated rash: Risk/benefit considerations in adults and children. Epilepsia1999;40:985—991.
44.
Messenheimer JA: Rash in adult and pediatric patients treated with lamotrigine. Can J Neurol Sci1998;25:S14—S18.
45.
Lamictal® (lamotrigine) Product Information. Research Triangle Park, NC, Glaxo Wellcome Inc, 2001.
46.
Rzany B., Mockenhaupt M., Baur S., et al: Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990—1992): Structure and results of a population-based registry. J Clin Epidemiol1996;49:769—773.
47.
Roujeau JC, Stern RS: Severe cutaneous reactions to drugs. N Engl J Med1994;331:1272—1285.
48.
Ueberall MA : Normal growth during lamotrigine monotherapy in pediatric epilepsy patients—A prospective evaluation of 103 children and adolescents. Epilepsy Res2001;46:63—67.
49.
Biton V., Mirza W., Montouris G., et al: Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology2001;56:172—177.
50.
Brodie MJ, Richens A., Yuen Awc, et al: Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet1995;345:476—479.
51.
Steiner TJ, Dellaportas CI, Findley LJ: Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin. Epilepsia1999;40:601—607.
